RP Bio Inc. (KOSDAQ:314140)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,950.00
+270.00 (4.75%)
At close: Jul 31, 2026
Market Cap51.56B -0.8%
Revenue (ttm)137.35B +9.5%
Net Income5.60B +328.6%
EPS647.79 +328.4%
Shares Out 8.67M
PE Ratio9.19
Forward PEn/a
Dividend50.00 (0.84%)
Ex-Dividend DateDec 29, 2025
Volume23,843
Open5,680.00
Previous Close5,680.00
Day's Range5,500.00 - 5,960.00
52-Week Range4,810.00 - 9,130.00
Beta0.47
Analystsn/a
Price Targetn/a
Earnings Daten/a

About RP Bio

RP Bio Inc., a bio-health company, engages in the research, development, manufacture, and sale of soft capsules in Korea and internationally. It offers animal, vegetable, antihistamine, and chewable soft capsules; hard capsules; and jelly and powder sticks; Urusa, flagship soft capsule; omega-3 and lutein products, and granule, effervescent granule, and stick type capsule powders. The company also provides cold and liver medicines; vitamins; blood circulation improvers; and pain relievers. The company was founded in 1983 and is headquartered in... [Read more]

Industry Pharmaceutical Preparations
Founded 1983
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 314140
Full Company Profile

Financial Performance

Financial Statements